201.58
5.94 (3.04%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Krystal Biotech, Inc. | Bullish | Bullish |
Stockmoo Score
|
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 221.00 (HC Wainwright & Co., 9.63%) | Buy |
| Median | 220.00 (9.14%) | |
| Low | 206.00 (Evercore ISI Group, 2.19%) | Buy |
| Average | 215.67 (6.99%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 192.81 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stifel | 11 Sep 2024 | 220.00 (9.14%) | Buy | 198.79 |
| HC Wainwright & Co. | 29 Aug 2024 | 221.00 (9.63%) | Buy | 195.22 |
| 28 Aug 2024 | 221.00 (9.63%) | Buy | 203.91 | |
| Evercore ISI Group | 12 Aug 2024 | 206.00 (2.19%) | Buy | 184.41 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 13 Sep 2024 | Announcement | Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference |
| 06 Sep 2024 | Announcement | Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference |
| 28 Aug 2024 | Announcement | Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté |
| 05 Aug 2024 | Announcement | Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates |
| 26 Jul 2024 | Announcement | Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |